|
1.
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008.
|
|
2.
|
Lendahl U, Zimmerman LB and McKay RD: CNS
stem cells express a new class of intermediate filament protein.
Cell. 60:585–595. 1990.
|
|
3.
|
Esni F, Stoffers DA, Takeuchi T and Leach
SD: Origin of exocrine pancreatic cells from nestin-positive
precursors in developing mouse pancreas. Mech Dev. 121:15–25.
2004.
|
|
4.
|
Delacour A, Nepote V, Trumpp A and Herrera
PL: Nestin expression in pancreatic exocrine cell lineages. Mech
Dev. 121:3–14. 2004.
|
|
5.
|
Ishiwata T, Kudo M, Onda M, Fujii T,
Teduka K, Suzuki T, Korc M and Naito Z: Defined localization of
nestin-expressing cells in L-arginine-induced acute pancreatitis.
Pancreas. 32:360–368. 2006.
|
|
6.
|
Parry S, Savage K, Marchio C and
Reis-Filho JS: Nestin is expressed in basal-like and triple
negative breast cancers. J Clin Pathol. 61:1045–1050. 2008.
|
|
7.
|
Carrière C, Seeley ES, Goetze T,
Longnecker DS and Korc M: The Nestin progenitor lineage is the
compartment of origin for pancreatic intraepithelial neoplasia.
Proc Natl Acad Sci USA. 104:4437–4442. 2007.
|
|
8.
|
Matsuda Y, Naito Z, Kawahara K, Nakazawa
N, Korc M and Ishiwata T: Nestin is a novel target for suppressing
pancreatic cancer cell migration, invasion and metastasis. Cancer
Biol Ther. 11:512–523. 2011.
|
|
9.
|
Micalizzi DS, Farabaugh SM and Ford HL:
Epithelialmesenchymal transition in cancer: parallels between
normal development and tumor progression. J Mammary Gland Biol
Neoplasia. 15:117–134. 2010.
|
|
10.
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: role
of phosphatidylinositol 39 kinase/AKT pathways. Oncogene.
24:7443–7454. 2005.
|
|
11.
|
Hay ED: The mesenchymal cell, its role in
the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 233:706–720. 2005.
|
|
12.
|
Casas E, Kim J, Bendesky A, Ohno-Machado
L, Wolfe CJ and Yang J: Snail2 is an essential mediator of
Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 71:245–254. 2011.
|
|
13.
|
Hotz B, Arndt M, Dullat S, Bhargava S,
Buhr HJ and Hotz HG: Epithelial to mesenchymal transition:
expression of the regulators snail, slug, and twist in pancreatic
cancer. Clin Cancer Res. 13:4769–4776. 2007.
|
|
14.
|
Liu J and Brown RE: Immunohistochemical
detection of epithelialmesenchymal transition associated with
stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp
Pathol. 3:755–762. 2010.
|
|
15.
|
Hay ED: An overview of
epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20.
1995.
|
|
16.
|
Birchmeier C, Birchmeier W and
Brand-Saberi B: Epithelialmesenchymal transitions in cancer
progression. Acta Anat (Basel). 156:217–226. 1996.
|
|
17.
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454.
2002.
|
|
18.
|
Kalluri R and Neilson EG:
Epithelial-mesenchymal transition and its implications for
fibrosis. J Clin Invest. 112:1776–1784. 2003.
|
|
19.
|
Taylor MA, Parvani JG and Schiemann WP:
The pathophysiology of epithelial-mesenchymal transition induced by
transforming growth factor-beta in normal and malignant mammary
epithelial cells. J Mammary Gland Biol Neoplasia. 15:169–190.
2010.
|
|
20.
|
Savagner P: Leaving the neighborhood:
molecular mechanisms involved during epithelial-mesenchymal
transition. Bioessays. 23:912–923. 2001.
|
|
21.
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005.
|
|
22.
|
Schaeffer DF, Assi K, Chan K, Buczkowski
AK, Chung SW, Scudamore CH, Weiss A, Salh B and Owen DA: Tumor
expression of integrin-linked kinase (ILK) correlates with the
expression of the E-cadherin repressor snail: an
immunohistochemical study in ductal pancreatic adenocarcinoma.
Virchows Arch. 456:261–268. 2010.
|
|
23.
|
Nieto MA, Sargent MG, Wilkinson DG and
Cooke J: Control of cell behavior during vertebrate development by
Slug, a zinc finger gene. Science. 264:835–839. 1994.
|
|
24.
|
Shields MA, Krantz SB, Bentrem DJ,
Dangi-Garimella S and Munshi HG: Interplay between β1-integrin and
Rho signaling regulates differential scattering and motility of
pancreatic cancer cells by snail and Slug proteins. J Biol Chem.
287:6218–6229. 2012.
|
|
25.
|
Montserrat N, Gallardo A, Escuin D,
Catasus L, Prat J, Gutiérrez-Avignó FJ, Peiró G, Barnadas A and
Lerma E: Repression of E-cadherin by SNAIL, ZEB1, and TWIST in
invasive ductal carcinomas of the breast: a cooperative effort? Hum
Pathol. 42:103–110. 2011.
|
|
26.
|
Cates JM, Byrd RH, Fohn LE, Tatsas AD,
Washington MK and Black CC: Epithelial-mesenchymal transition
markers in pancreatic ductal adenocarcinoma. Pancreas. 38:e1–e6.
2009.
|
